CTIB posts revenue growth and small operating profit but is cash-strapped, warns going-concern
StockInvest.us
Yunhong Green CTI, Ltd (NASDAQ: CTIB)
Quick read - what's happening inside: the company posted sequential revenue growth, improved quarterly operating result (small positive operating income), and materially stronger operating cash flow - but it remains cash-poor, highly customer-concentrated, and carries a going-concern warning plus material internal control weaknesses.
Key points & facts
* Net sales - Q2 (three months ended June 30, 2025): $5,457,000; six months: $10,259,000.
* Gross profit - Q2: $978,000 (gross margin ~18%); six months: $1,844,000 (gross margin ~18%).
* Income (loss) from operations - Q2: $19,000 (positive); six months: $(159,000).
* Net loss - Q2: $(185,000); six months: $(601,000).
* Net loss attributable to common shareholders - Q2: $(228,000); six months: $(687,000).
* Cash and cash equivalents at June 30, 2025: $18,000 (down from $220,000 at 12/31/24).
* Accounts receivable (net): $3,795,000; Inventories: $8,180,000.
* Total assets: $22,736,000; Total liabilities: $11,385,000; Total shareholders' equity: $11,351,000.
* Revolving line of credit balance: $4,746,000 (available borrowing approx. $1.3M as of 6/30/25).
* Term loan balance: ~ $564,000 (reported as notes payable / term loan approx $0.6M).
* Customer concentration: two customers represented ~82% of Q2 sales (Customer A 38%; Customer B 44%); amounts owed by these customers = $3,484,000 (≈89% of accounts receivable).
* Warrants outstanding: 556,000 at $1.52 exercise price (exercisable through March 2027).
* Preferred cumulative accrued dividends (June 30, 2025): Series E ~$149k; Series F ~$80k (total ~ $229k accrued).
* Subsequent event: received $315,000 settlement cash on July 29, 2025 (to be recognized in Q3 2025).
Income statement - positives
* Revenue growth: Q2 sales up 25% year-over-year (Q2 2025 $5.457M vs Q2 2024 $4.354M); six‑month sales +11% YoY.
* Gross margin improved slightly (82% cost of sales in 2025 vs 84% in Q2 2024) - cost discipline on COGS relative to sales.
* Quarter moved to a small operating profit: operating income of $19k in Q2 2025 vs $(171k) in Q2 2024 - shows operating leverage kicking in seasonally.
* Operating cash flow turned strongly positive: net cash provided by operations $1,714,000 in first half of 2025 (vs $108,000 in H1 2024).
Income statement - negatives
* Still unprofitable on the six‑month basis: net loss $(601,000) for H1 2025; net loss attributable to common $(687,000).
* Interest expense remains meaningful: $227,000 in Q2 and $465,000 YTD, pressuring net income.
* Very thin margins overall (gross margin ~18%): limited cushion vs higher input costs or tariffs.
* Heavy reliance on two customers - revenue volatility risk and receivable concentration (89% of AR tied to two customers).
Liquidity, governance & operational risks
* Extremely low cash balance ($18k) - liquidity strained despite positive operating cash flow in H1; net decrease in cash of $202k for the six months.
* Material doubt about going concern - management explicitly warns there is substantial doubt about the company's ability to continue for one year without additional financing or improved performance.
* Credit facility timing: senior facility extended to Sept 30, 2025 (auto-renewal possible); revolver balance $4.746M with ~$1.3M available - refinancing / renewal risk exists.
* Internal control weakness: management disclosed a material weakness (insufficient accounting staff/experience) related to equity financings and timing of non-cash charges; disclosure controls were not effective as of 6/30/25.
* Nasdaq compliance risk: notice for minimum $1.00 bid price; company has until Oct 19, 2025 to regain compliance (or consider reverse split or other actions).
Catalysts & near-term items to watch
* Q3 recognition of $315,000 settlement - positive one-time income boost.
* Potential warrant exercises or preferred conversions (556k warrants reserved) - could bring capital if exercised but also dilute.
* Revolver renewal or alternative financing - timing (facility maturity/renewal) and terms will be critical for liquidity.
* Customer order timing (seasonality around Valentine's Day) - shipment timing materially affects quarterly results.
Bottom line: CTIB shows revenue momentum, a swing to a small operating profit in Q2 and improved operating cash flow - but the company remains cash‑strained, highly concentrated with two customers, exposed to debt/credit facility timing, and flagged for material control weaknesses and going‑concern risk. Short-term upside hinges on financing execution, collection of receivables, and the one‑time Q3 settlement; downside remains significant if capital access tightens or top customers reduce orders.
About The Author
StockInvest.us
StockInvest.us is a stock market research tool that provides daily stock signals and technical analysis for over 25 000 tickers on 38 exchanges. The company was founded in 2016 in Vilnius, Lithuania.
Read Next in Income Statements
Sign In